We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genetic Loci Link Plasma Lipid Levels to CVD Risk

By LabMedica International staff writers
Posted on 07 Oct 2019
Print article
Image: The lipodome in connection with the total interactome of a cell (Photo courtesy of Wikimedia Commons).
Image: The lipodome in connection with the total interactome of a cell (Photo courtesy of Wikimedia Commons).
A team of Finnish and international researchers utilized both genomics and lipidomics approaches to identify novel genetic variants associated with plasma levels of lipid species and linked these levels to cardiovascular disease (CVD) risk.

The lipidome refers to the totality of lipids in cells. The human plasma lipidome consists of almost 600 distinct molecular species. Research results have suggested that the lipidome of an individual may be able to indicate cancer risks associated with dietary fats, particularly breast cancer.

While some plasma lipids such as cholesterol and triglycerides are well-established heritable risk factors for CVD, hundreds of other lipid species are known risk factors for cardiovascular disease but have not been well characterized. In this regard, investigators at the University of Helsinki (Finland) and their collaborators sought to establish links between lipid levels and cardiovascular disease risk. Specifically, they aimed to (1) determine heritability of lipid species and their genetic correlations; (2) identify genetic variants influencing the plasma levels of lipid species; (3) test the relationship between identified lipid–species-associated variants and CVD manifestations and (4) gain mechanistic insights into established lipid variants.

For this study, they performed genome-wide association analyses of 141 lipid species (in 2,181 individuals), followed by phenome-wide scans with 25 CVD related phenotypes of 511,700 individuals.

Results showed that the scans had identified 35 lipid-species-associated loci, 10 of which associated with CVD risk including five new loci. Furthermore, they found that lipoprotein lipase (LPL) more efficiently hydrolyzed medium length triacylglycerides (TAGs) than others. Polyunsaturated lipids had the highest heritability and genetic correlations, suggesting considerable genetic regulation at fatty acids levels.

"Our study demonstrates that lipidomics enables much deeper insights into the genetic regulation of lipid metabolism. We hope that the openly available browser will in part help future biomarker and drug target discovery and build our understanding of the pathways connecting genetic variation to cardiovascular and other lipid-related diseases", said senior author Dr. Samuli Ripatti, professor of biometry at the University of Helsinki.

The study was published in the September 24, 2019, online edition of the journal Nature Communications and the data are freely available on the Internet at https://mqtl.fimm.fi.

Related Links:
University of Helsinki

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Amoebiasis Test
ELI.H.A Amoeba
New
PSA Test
Humasis PSA Card

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.